Advertisement
News and applications for life science research professionals
Subscribe to Bioscience Technology All
View Sample

FREE Email Newsletter Bioscience Technology Daily

DNA Mapping of Tumors Predicts Drug Response 2/13/04

February 13, 2004 12:57 pm | Articles | Comments

by Elizabeth Tolchin Optical mapping of DNA derived from brain tumors (oligodendrogliomas) could help pinpoint the genetic variation that determines the effectiveness of drug therapies in patients, according to researchers.

TOPICS:

"Dead" Genes Influence Drug Development 2/12/04

February 12, 2004 12:42 pm | Articles | Comments

by Elizabeth Tolchin Are pseudogenes important for understanding the human genome? Yes, says a group from Yale who catalogued 8,000 processed pseudogenes in the human genome.

TOPICS:

Contract Laboratory Completes an Agreement, Extends Another, 2/11/04

February 11, 2004 10:57 am | Articles | Comments

by Tariq Malik, a freelance writer based in Queens, N.Y. An alliance between Pfizer Inc., New York, and the discovery chemistry provider ChemBridge Research Laboratories LLC (CRL), San Diego, has grown beyond its initial goal to produce advanced screening libraries for the global pharmaceutical giant.

TOPICS:
Advertisement

Cooperation Between Industry, FDA Leads to Rebound in Drug Innovation 2/10/04

February 10, 2004 10:53 am | Articles | Comments

by Don Monroe, PhD The US Food and Drug Administration reported in January what it called a rebound in approval of innovative drugs in 2003.

TOPICS:

Phospho-ERK2 ELISA

February 10, 2004 6:57 am | Articles | Comments

Phospho-ERK1/ERK2 DuoSet® IC ELISA Development System kits (R&D Systems) provide an alternative to Western blots for intracellular factors involved in signal transduction, apoptosis, and transcription.

Anti-human TCR Antibodies

February 10, 2004 6:57 am | Articles | Comments

Anti-human TCR V?12.1 monoclonal antibody is for validated applications including flow cytometry, immunoprecipitation, frozen tissue staining, and T cell activation. Anti-human TCR V?6.

Untouched B Cell Isolation

February 10, 2004 6:57 am | Articles | Comments

Miltenyi Biotec has announced the release of several new MACS® products for the isolation of untouched human B cells.

TOPICS:

Fluorescent Screening For Kinase, Phosphatase Inhibitors

February 10, 2004 6:57 am | Articles | Comments

The Z'-LYTE™ assay platform (Invitrogen Corp.) provides a fluorescence-based biochemical

Advertisement

Inhibin B ELISA

February 10, 2004 6:57 am | Articles | Comments

Diagnostic Systems Laboratories, Inc. has launched an Inhibin B ELISA. It is specific for dimeric Inhibin B, does not require sample pretreatment, and can be fully automated on open-platform microplate systems.

TAFI (Thrombin Activatable Fibrinolysis Inhibitor) Assay

February 10, 2004 6:57 am | Articles | Comments

Pefakit® TAFI is a highly specific, 2-step chromogenic assay for the measurement of TAFI (Thrombin Activatable Fibrinolysis Inhibitor) in plasma.

HSP27 (Heat Shock Protein) ELISA

February 10, 2004 6:57 am | Articles | Comments

HSP27 [pS82] phosphoELISA™ is sensitive to 1,000 cells/well, demonstrated with HeLa cell lysates. Additional validated cell lines include THP-1, HT1080, Jurkat and 293 cells.

HDAC8 Activity Assay

February 10, 2004 6:57 am | Articles | Comments

HDAC8 Colorimetric/Fluorometric Activity Assay/Drug Discovery Kit is HTS-friendly assay and allows real-time monitoring of HDAC activity. This is made possible by HDAC-TRAC™ substrate and buffer, which also enables a choice of either colorimetric or fluorometric detection.

Chemiluminescent Substrate (2747)

February 10, 2004 6:57 am | Articles | Comments

BioFX's chemiluminescent substrates are used in immunoassay and immunoblotting applications. The reagents are intensified and the signal duration increased by proprietary enhancers.

Characterize, Quantify IgG Purity And Heterogeneity

February 10, 2004 6:57 am | Articles | Comments

ProteomeLab™ IgG purity/heterogeneity assay (Beckman Coulter) is offered in kit format with a validated standard operating protocol (SOP).

Anti-STEAP Polyclonal

February 10, 2004 6:57 am | Articles | Comments

STEAP (Six-transmembrane epithelial antigen of the prostate) is a prostate-specific cell surface antigen that is highly expressed in human prostate cancers. STEAP is unique among cell surface prostate antigens in its potential function as a channel or transport protein.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading